Home › J&J and Bavarian Nordic start clinical tests of Ebola vaccine
 

Keywords :   


J&J and Bavarian Nordic start clinical tests of Ebola vaccine

2015-01-06 12:01:28| Biotech - Topix.net

Johnson & Johnson has started clinical trials of its experimental Ebola vaccine, which uses a booster from Denmark's Bavarian Nordic, making it the third such shot to enter human testing. The initiation of the Phase I study, which had been expected about now, marks further progress in the race to develop a vaccine against a disease has killed more than 8,000 people in West Africa since last year.

Tags: start tests clinical nordic

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Dine and dash couple hit my pizzeria, says owner
15.05Boeing may face criminal prosecution, US says
15.05Indian spices face heat over global safety concerns
15.05'Corrupt ship inspectors demand our food and cargo'
15.05Taylor Swift Eras Tour to boost UK spending by 1bn, says report
15.05Three ways to win the rental property race
15.05Renters in scrum for homes as listing time slashed
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
More »